Notice of extraordinary general meeting
Filed with HKEX · Stock code 1779 · · 2 pages · English
Summary by 6ix AI
This filing is a notice for an extraordinary general meeting of LongBio Pharma (Suzhou) Co., Ltd., detailing the agenda and resolutions to be considered by shareholders. The meeting will address proposed amendments to the Articles of Association regarding share capital and compliance with domestic laws. Shareholders are informed about the voting process and requirements for attending the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LongBio Pharma (Suzhou) Co., Ltd. on 6ix
Earlier from LongBio Pharma (Suzhou)
- Proposed amendments to the articles of association and notice of extraordinary general meeting
- Proposed amendments to the articles of association
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
Later from LongBio Pharma (Suzhou)
- Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
- Voluntary announcement topline data from the phase ii clinical trial in china of LP-005 for the treatment of pnh
Follow LongBio Pharma (Suzhou) into a list and get an email when it puts out news.
Follow LongBio Pharma (Suzhou)